Back to search

Article

Integrating Network Pharmacology and Experimental Validation to Elucidate Huaier in Attenuating Liver Fibrosis via the AKT Signaling Pathway

2026-03-20

Abstract excerpt

<title>Abstract</title> <p>Liver fibrosis, a critical pathological precursor to cirrhosis and hepatocellular carcinoma, represents a significant unmet global health challenge due to the lack of effective targeted therapies that can reverse established fibrotic scarring. An integrated strategy was employed. Network pharmacology identified potential targets, followed by molecular docking and dynamics simulations. I...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4a7510f6-1a3c-59af-9b1a-0a05ce02a945
DOI
10.21203/rs.3.rs-9123161/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrating Network Pharmacology and Experimental Validation to Elucidate Huaier in Attenuating Liver Fibrosis via the AKT Signaling PathwayDOI 10.21203/rs.3.rs-9123161/v1
Development of A Novel Anti-Liver Fibrosis Formula with luteolin, licochalcone A, aloe-emodin and acacetin by network pharmacology and transcriptomics analysisSemantic proximity
An LSEC-focused computational drug repurposing platform for liver fibrosis: Identification of vorinostat and other LSEC-protective candidatesSemantic proximity
Mechanisms of Yinchen combined with Huangbai against Non-alcoholic fatty liver disease based on Network pharmacology, Molecular docking and Molecular Dynamics SimulationsSemantic proximity
Integrated in silico dissection of ABC transporter- mediated hepatoprotective by apigenin and luteolin from Eclipta prostrata using network pharmacology, molecular docking and ADME-toxicity profilingSemantic proximity
Notoginsenoside R1 targets PPAR-γ to inhibit Hepatic Stellate Cell activation and ameliorates liver fibrosisSemantic proximity
Network Pharmacology and Molecular Docking Reveal the Mechanism of Isodon Ternifolius (D. Don) Kudo Against Liver FibrosisSemantic proximity
Rationale and targets for antifibrotic therapies.Semantic proximity
AI-assisted Drug Re-purposing for Human Liver FibrosisSemantic proximity
The Therapeutic Potential of Chi Shao and Fu Zi in Acute-on-Chronic Liver Failure: Insights from Network Pharmacology and Animal StudiesSemantic proximity
Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysisSemantic proximity
Huanglian-Hongqu herb pair improves nonalcoholic fatty liver disease via NF-κB/NLRP3 pathway in mice: network pharmacology, molecular docking and experimental validationSemantic proximity
Unraveling Berberine's Multi-Target Mechanism in Combating NAFLD: A Network Pharmacology and In Vitro StudySemantic proximity
Select a neighboring publication to make it the new centre.